Terns Pharmaceuticals, Inc. - stock earnings
TERN Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q4 | -21.0 million USD | ? USD |
| 2023Q3 | -29.8 million USD | ? USD |
| 2023Q2 | -17.9 million USD | ? USD |
| 2023Q1 | -21.5 million USD | ? USD |
| 2022Q4 | -15.8 million USD | ? USD |
| 2022Q3 | -16.8 million USD | ? USD |
| 2022Q2 | -13.9 million USD | ? USD |
| 2022Q1 | -13.8 million USD | ? USD |
| 2021Q4 | -14.2 million USD | 1.0 million USD |
| 2021Q3 | -11.8 million USD | 2 USD |
| 2021Q2 | -10.7 million USD | 36 USD |
| 2021Q1 | -13.3 million USD | ? USD |
| 2020Q4 | -9.9 million USD | ? USD |
| 2020Q3 | -11.4 million USD | ? USD |
| 2020Q2 | -9.7 million USD | ? USD |
| 2020Q1 | -9.0 million USD | ? USD |
| 2019Q4 | -9.8 million USD | ? USD |
TERN Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -90.2 million USD | ? USD |
| 2022 | -60.3 million USD | ? USD |
| 2021 | -50.2 million USD | 1.0 million USD |
| 2020 | -40.6 million USD | ? USD |
| 2019 | -68.8 million USD | ? USD |
| 2018 | -17.7 million USD | ? USD |
TERN
Price: $5.44
52 week price:
Earnings Per Share: -1.27 USD
P/E Ratio: -6.83
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 59800
Market Capitalization: 303.2 million